Skip to content

Clinical trials

Dysbiosis trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dysbiosis Country / region: Italy Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20161
20191
20202
20214
20224
20233
20242
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Unknown status4
Recruiting2
Enrolling by invitation1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Azienda di Servizi alla Persona di Pavia2
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico2
Fondazione Policlinico Universitario Agostino Gemelli IRCCS2
University of Turin, Italy2
Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis1
Azienda Ospedaliera Universitaria Senese1
Casa di Cura Dott. Pederzoli1
IRCCS San Raffaele1
Liaquat University of Medical & Health Sciences1
Lo.Li.Pharma s.r.l1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dysbiosis20
Inflammation3
Irritable Bowel Syndrome3
Abdominal Pain2
COVID-192
Diarrhea2
Post-Acute COVID-19 Syndrome2
Acute Coronary Syndrome1
Carcinoma, Hepatocellular1
Celiac Disease1

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.